John Sevcik, DPM
Podiatrist · Lees Summit, MONPI 1932728490
Payments from drug & device makers
What this record shows
This record is dominated by education: $3,600 of the $5,446 with a category attached, or 66.1%. Rock Medical Orthopedics, Inc. accounts for 66.1% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $3,727 and has fallen 72.4% since, to $1,030 in 2025.
Across 47 payments — averaging $115.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rock Medical Orthopedics, Inc.$4K
- Stryker$1K
- Orthofix Medical, Inc.$148
- Smith+Nephew$136
- Kerecis Limited$92
- Organogenesis Inc.$78
- plus $266 from 7 others
What the payments were for
- Travel & lodging$52310%
- Food & beverage$1,32324%
- Education$3,60066%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rock Medical Orthopedics, Inc. | 3 | $3,600 |
| Stryker | 22 | $1,126 |
| Orthofix Medical, Inc. | 1 | $148 |
| Smith+Nephew | 4 | $136 |
| Kerecis Limited | 3 | $92 |
| Organogenesis Inc. | 2 | $78 |
| Acera Surgical, Inc. | 3 | $76 |
| Access Pro Medical, LLC | 3 | $58 |
| KCI USA, Inc. | 2 | $36 |
| Integra Lifesciences Corporation | 1 | $32 |
| Titan Surgical Group, LLC | 1 | $28 |
| Next Science LLC | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$611
- Physio-Stim$148
- TRUELOK SYSTEM$148
How this compares
$5,446 in reported general payments places this provider in the 80th percentile of 105 podiatrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 32 | $417 |
| Terbinafine Hcl | 68 | $323 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $289 |
| Gabapentin | 20 | $117 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $106 |
| Silver Sulfadiazine | 15 | $100 |
| Methylprednisolone | 12 | $75 |
| Cephalexin | 15 | $37 |
| Meloxicam | 26 | $33 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Lees Summit
- William DukeJefferson City$54K
- Kiera Benge-SheaSaint Louis$28K
- Thomas BoldryLiberty$19K
- Ryan FrankIndependence$15K
- Neil ErmitanoSaint Louis$14K
- John HarnessOverland$14K
- Brittany StaplesCreve Coeur$13K
- Daniel NarowitzSaint Louis$12K
- Jay MoradiaSaint Louis$11K
- Ellen ColganWarrenton$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.